Uncovering the origins of a niche-Reference-Cited by-同舟云学术

Uncovering the origins of a niche

Published:2014-11-11 Issue: Volume:3 Page:
ISSN:2050-084X
Container-title:eLife
language:en
Short-container-title:

Author:

Bernitz Jeff M¹,Moore Kateri A²

Affiliation:

1. Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, United States

2. Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, United States

Abstract

Multiple cell types that share a common origin cooperate to form a supportive niche for stem cells that give rise to blood and to the cells of the immune system.

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://cdn.elifesciences.org/articles/05041/elife-05041-v1.pdf

Reference8 articles.

1. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches;Ding;Nature,2013

2. Endothelial and perivascular cells maintain haematopoietic stem cells;Ding;Nature,2012

3. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance;Greenbaum;Nature,2013

4. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function;Isern;eLife,2014

5. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow;Katayama;Cell,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis;Pharmacological Research;2022-09

2. Human ESC-derived Neuromesodermal Progenitors (NMPs) Successfully Differentiate into Mesenchymal Stem Cells (MSCs);Stem Cell Reviews and Reports;2021-10-20

3. To condition or not to condition—That is the question: The evolution of nonmyeloablative conditions for transplantation;Experimental Hematology;2016-08